Marketplace

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 1616
Newswise: DromosPTM™, an Innovative Software for Specialty Pharmacies

Article ID: 718579

DromosPTM™, an Innovative Software for Specialty Pharmacies

Henry Ford Health System

Henry Ford Innovations (HFI) has signed an exclusive licensing agreement with a Detroit software and health care company to market an innovative software application that will be appealing to specialty pharmacies worldwide.

Released:
6-Sep-2019 1:00 PM EDT
Newswise: Premium Wine & Spirits Distributor Partners to Prevent Counterfeit Alcohol

Article ID: 717858

Premium Wine & Spirits Distributor Partners to Prevent Counterfeit Alcohol

SafeProof.org

Incidents related to methanol and counterfeit alcohol are increasing around the world. A leading international Wine & Spirits distributor is taking proactive steps to promote awareness and insure their popular liquor and wine brands are authentic and safe.

Released:
22-Aug-2019 10:25 AM EDT

Article ID: 717706

JOGO HEALTH to present evidence of digital therapeutics at ANZSCoS Annual Scientific Meeting

JOGO Health Inc.

JOGOHEALTH Inc., a privately held digital therapeutics company focused on the development and commercialization of treatments for neuromuscular (NM) conditions such as stroke, spinal cord injury, cerebral palsy and urinary incontinence today announced that it will present evidence and performance of its lead investigational product JOGO, at the 2019 Australian & New Zealand Spinal Cord Society (ANZSCoS) Annual Scientific Meeting held at Pullman Melbourne Albert Park in Melbourne, Australia from 21 - 23 August 2019.

Released:
20-Aug-2019 9:00 AM EDT

Marketplace

Languages:

English

Article ID: 717154

Precision Matters

71st AACC Annual Scientific Meeting Press Program

Samplla™, a family of specimen collection devices which are designed to provide ambient transportation for up to 21 days. Specimens applied to Samplla™ are immediately “dried and stabilized” within a local atmospheric condition using its Samplla Modified Atmosphere Packaging (sMAP), that provides an atmosphere separated from the ambient atmosphere and resistant to gas exchange – the result, stability. Samplla™ S device, the first product of this line of products was perfected to collect, transport and store bodily fluid specimens.

Released:
8-Aug-2019 6:30 AM EDT
Newswise: Beckman Coulter’s DxH 520 Hematology Analyzer receives Scientists’ Choice Award and Named Best New Clinical Product

Article ID: 717072

Beckman Coulter’s DxH 520 Hematology Analyzer receives Scientists’ Choice Award and Named Best New Clinical Product

71st AACC Annual Scientific Meeting Press Program

Beckman Coulter’s DxH 520 Hematology Analyzer receives Scientists’ Choice Award and Named Best New Clinical Product

Released:
7-Aug-2019 10:05 AM EDT

Article ID: 717060

Fluent in All Languages

71st AACC Annual Scientific Meeting Press Program

Samplla™, a family of specimen collection devices which are designed to provide ambient transportation for up to 21 days. Specimens applied to Samplla™ are immediately “dried and stabilized” within a local atmospheric condition using its Samplla Modified Atmosphere Packaging (sMAP), that provides an atmosphere separated from the ambient atmosphere and resistant to gas exchange – the result, stability. Samplla™ S device, the first product of this line of products was perfected to collect, transport and store bodily fluid specimens.

Released:
7-Aug-2019 9:00 AM EDT
Newswise: Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row

Article ID: 717061

Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row

71st AACC Annual Scientific Meeting Press Program

Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row

Released:
7-Aug-2019 1:05 AM EDT

Article ID: 717036

Quest Diagnostics Now Participating in NCI-MATCH Precision Medicine Clinical Trial

71st AACC Annual Scientific Meeting Press Program

As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial. Both the Quest Med Fusion 50SEQ cancer panel and IBM Watson Genomics from Quest Diagnostics service fulfill the trial's criteria for accuracy and reliability in tumor profiling.

Released:
6-Aug-2019 2:05 PM EDT

Article ID: 717032

Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease

71st AACC Annual Scientific Meeting Press Program

The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages

Released:
6-Aug-2019 2:05 PM EDT

Showing results

110 of 1616

Chat now!